Publications:

Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment.

Molecular & Cellular Oncology

Castel, Pau P; Toska, Eneda E; Zumsteg, Zachary S ZS; Carmona, F Javier FJ; Elkabets, Moshe M; Bosch, Ana A; Scaltriti, Maurizio M

Publication Date: 2014

Variant appearance in text: PI3K: N345L

PubMed Link: 27308344

Variant Present in the following documents:

• Main text

View BVdb publication page

Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.

Cancer Research

Dogruluk, Turgut T; Tsang, Yiu Huen YH; Espitia, Maribel M; Chen, Fengju F; Chen, Tenghui T; Chong, Zechen Z; Appadurai, Vivek V; Dogruluk, Armel A; Eterovic, Agna Karina AK; Bonnen, Penelope E PE; Creighton, Chad J CJ; Chen, Ken K; Mills, Gordon B GB; Scott, Kenneth L KL

Publication Date: 2015-12-15

Variant appearance in text: PIK3CA: N345l

PubMed Link: 26627007

Variant Present in the following documents:

• Main text

View BVdb publication page